Analysis of long-term exposure to momelotinib in the Phase III SIMPLFY myelofibrosis trials VJHemOnc – Video Journal of Hematology & HemOnc 2:07 3 years ago 111 Скачать Далее
Safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:20 1 year ago 292 Скачать Далее
Latest updates on momelotinib: safety, durability of response & survival benefit VJHemOnc – Video Journal of Hematology & HemOnc 3:02 1 year ago 404 Скачать Далее
SIMPLIFY-1+2 trial: What is the long-term benefit of momelotinib treatment in R/R MF? MPN Hub 4:04 3 years ago 156 Скачать Далее
An insight into the MOMENTUM trial: safety and efficacy of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 354 Скачать Далее
The latest data on momelotinib for MPNs VJHemOnc – Video Journal of Hematology & HemOnc 4:15 3 years ago 184 Скачать Далее
Indirect Treatment Comparison Shows Momelotinib Has ‘Favorable’ Safety in Myelofibrosis Blood Cancers Today 5:25 1 year ago 98 Скачать Далее
Long-term momelotinib exposure in JAKi-naïve or previously JAKi-treated myelofibrosis patients VJHemOnc – Video Journal of Hematology & HemOnc 2:28 3 years ago 100 Скачать Далее
Indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:16 1 year ago 108 Скачать Далее
Indirect comparison of momelotinib vs pacritinib safety and anemia outcomes in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:28 10 months ago 105 Скачать Далее
Momelotinib for the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:40 4 years ago 202 Скачать Далее
Efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from MOMENTUM VJHemOnc – Video Journal of Hematology & HemOnc 3:48 2 years ago 301 Скачать Далее
Recent updates from the MOMENTUM trial and the value of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 1:53 1 year ago 116 Скачать Далее
Momelotinib Versus Danazol in Symptomatic Patients with Anaemia and Myelofibrosis (MOMENTUM) International Academy for Clinical Hematology IACH 40:16 1 year ago 365 Скачать Далее
The promise of momelotinib in the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:00 1 year ago 536 Скачать Далее
MOMENTUM & the potential impact of approval of momelotinib in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:20 1 year ago 515 Скачать Далее
FDA Approves JAK Inhibitor Momelotinib for Myelofibrosis in Anemic Adults Medical Dialogues 2:25 11 months ago 218 Скачать Далее
COMFORT: Five-Year Outcomes of Ruxolitinib in Patients With Myelofibrosis American Society of Hematology 3:20 8 years ago 2 857 Скачать Далее
Update on JAK Inhibitors for Myelofibrosis: There is more than one HMP Education 25:13 8 years ago 1 076 Скачать Далее
Optimizing current treatment approaches in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:33 1 year ago 866 Скачать Далее
